Grantham, Mayo, Van Otterloo & Co (GMO)
NGVT icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Ingevity NGVT Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,700
Closed -$336K – 727
2023
Q1 		$336K Buy
4,700
+400
+9% +$31.7K ﹤0.01% 605
2022
Q4 		$303K Buy
+4,300
New +$303K ﹤0.01% 632

Other funds holding NGVT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ICP
Inclusive Capital Partners San Francisco, California $26M AUM 22.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
SAM
Southernsun Asset Management Memphis, Tennessee $690M AUM 30.68% 1-Year Est. Return
BBCM
Broad Bay Capital Management New York $1.18B AUM 65.45% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s NGVT Position: Q2 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Ingevity (NGVT) in Q2 2023, closing a stake of 4,700 shares — an estimated $336K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NGVT in Q4 2022 and held it in 2 quarters. The position peaked at $336K in Q1 2023. 251 funds tracked by Wall St. Rank hold NGVT as of Q2 2023.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Ingevity position as of Q2 2023 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 4,700 Ingevity shares in Q2 2023, an estimated $336K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Ingevity in Q4 2022 and held it in 2 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Ingevity position peaked at $336K in Q1 2023.
  • 251 funds tracked by Wall St. Rank held Ingevity as of Q2 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2023, filed 14 Aug 2023.